Natasha Khrystolubova, RPh, BPharm, BCOP

Position

Pharmacist Liaison

Natasha Khrystolubova is the Director of Pharmacy Clinical Services at Rx To Go, the medically integrated pharmacy for Florida Cancer Specialists & Research Institute (FCS). Natasha is actively involved in developing and managing innovative clinical programs to optimize oral oncology medications across the statewide practice, primarily focusing on patient medication adherence and persistence on therapy. As a Board-Certified Oncology Pharmacist with a graduate certification in Precision Medicine from the University of Florida, Natasha leads in developing, implementing, and expanding comprehensive clinical education on drug efficacy, safety, and side effect management. Natasha’s responsibilities include participating in the FCS Pharmacy and Therapeutics committee, Precision Medicine Advisory Board for Amerisource-Bergen, and collaboration with the FCS Informatics and MolecularHelp teams. She is closely engaged with pharmaceutical companies in reviewing new oral oncology therapies and real-world drug “behavior” after approval.

 Natasha’s clinical expertise has allowed her to make significant contributions to advancing the position of Rx To Go and FCS towards excellence and prominence. She is a well-respected, exemplary leader within community oncology and has an excellent vision for patient care in a community-based, real-world setting.

 Natasha and her team published the results of their successful work with cancer patients on oral oncology therapies in the Journal of Oncology Pharmacy Practice/SAGE Journals and the American Journal of Managed Care.

Natasha graduated from the Medical Institute/ Pharmacy faculty in Irkutsk, Russia. She received her pharmacy license in the US in 1996.  Before joining FCS in 2011, Natasha held clinical pharmacist and leadership positions in hospitals and home-infusion specialty pharmacy settings. She is a member of several professional pharmacy associations, including NCODA, COA, COPA, and HOPA, and serves as an advisor to help develop standard, patient-focused management processes for using oral medications in cancer care. Natasha is an NCODA International Executive Council member, including pharmacists and doctors from oncology practices in Croatia, Morocco, England, Brazil, Poland, and Greece.

In her spare time, Natasha enjoys jogging, reading a good thriller, listening to podcasts, traveling the world, and cycling in Europe.